Frank Ruffo Net Worth & Insider Trades

Frank Ruffo - Chief Financial Officer, Aclaris Therapeutics, Inc

As of March 14, 2022

What is Frank Ruffo's Net Worth?

The current estimated net worth of Aclaris Therapeutics, Inc's Chief Financial Officer, Frank Ruffo, is estimated to be about $5.66M . Frank Ruffo owns about 201,883 units of Aclaris Therapeutics, Inc common stock. In the last 7 years at Aclaris Therapeutics, Inc, Frank Ruffo has sold an estimated value of $3.22M worth.

What is Frank Ruffo's Past Insider Trading?

Frank Ruffo's largest purchase order was 1,250 units , worth over $22.77K on May 7, 2018. Frank Ruffo's largest sale order was 87,339 units , worth over $2.31M on April 26, 2021. In total, Frank Ruffo has made about 29 transactions over 7 years of their time at Aclaris Therapeutics, Inc. Frank Ruffo usually trades in December, with the busiest year in 2018. The most recent transaction was a sale order of 12,823 units , worth over $199.33K on March 14, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Frank Ruffo's' Mailing Address?

  • Mailing address is C/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA 19355 PA

What are Aclaris Therapeutics, Inc's Past Insider Trades?

Aclaris Therapeutics, Inc's most recent insider trade came on November 14, 2022 by Andrew Schiff who sold 53,926 units worth $919.59K . In the last 7 years, insiders at Aclaris Therapeutics, Inc have sold an estimated value of $94.33M and bought an estimated value of $61.5M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Kamil Alijackson, Chief Legal Officer,  Frank Ruffo, Chief Financial Officer,  and Neal Walker, President and CEO .

Aclaris Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1